Physician
Internal Medicine
Dr. Ronald L. Prigeon, MD
|
|
Give Review
Doctor Ronald L. Prigeon, MD practices Internal Medicine. He graduated from University of Nebraska Medical Center. University of Nebraska Medical Center is a one of the best medicals schools. University of Nebraska Medical Center is ranked 60/4 in Research/PrimaryCare. Doctor Ronald L. Prigeon, MD is a published doctor and has 41 publications published. The lastest was: 'Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.'
Publications
- Improved Glycemic Control Enhances the Incretin Effect in Patients With Type 2 Diabetes.
- Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.
- Hepatic Lipase Gene -514C>T Variant is Associated with Exercise Training-Induced Changes in VLDL and HDL by Lipoprotein Lipase.
- Gastric bypass surgery enhances glucagon-like Peptide 1-stimulated postprandial insulin secretion in humans.
- Weight Loss and Low-Intensity Exercise for the Treatment of Metabolic Syndrome in Obese Postmenopausal Women.
- Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.
- Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.
- Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
- Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes.
- Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses.
- Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults.
- Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
- Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.
- Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
- Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.
- Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
- Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies.
- Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.
- Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans.
- Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.
- Reliability of error estimates from the minimal model: implications for measurements in physiological studies.
- The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects.
- Proinsulin as a marker for the development of NIDDM in Japanese-American men.
- Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity--clinical res...
- Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I.
- Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects.
- Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.
- Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.
- The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
- Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
- Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding.
- Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.
- Endogenous somatostatin-28 modulates postprandial insulin secretion. Immunoneutralization studies in baboons.
- Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms.
- Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus.
- Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
- Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
- The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.
- Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.
- Effects of glucagon-like peptide 1 on the hepatic glucose metabolism.
Schools
University of Nebraska College of Medicine
University Nebr Hosps Clins
University of Washington
Conditions Treated
- Hyperlipidemia
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Aetna
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
Education
-
University of Washington -
University of Nebraska Medical Center -
University of Nebraska College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Donald P. Bousel, MD |
|
|
Dr. Santosh N. Raiker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonard A. Sowah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen P. Juraschek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel D. Meshulam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott A. Feeser, MD
This Doctor is OpenDoctor Recommended.
|